Short Interest in Venus Concept Inc. (NASDAQ:VERO) Decreases By 99.2%

Venus Concept Inc. (NASDAQ:VERO) saw a significant drop in short interest in the month of February. As of February 15th, there was short interest totalling 600 shares, a drop of 99.2% from the January 31st total of 73,100 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 544,000 shares, the short-interest ratio is presently 0.0 days.

Venus Concept Stock Performance

Shares of NASDAQ VERO traded down $0.02 during midday trading on Thursday, reaching $0.30. 491,365 shares of the company traded hands, compared to its average volume of 653,069. The stock has a 50-day moving average price of $0.36 and a 200 day moving average price of $0.43. The company has a market cap of $2.17 million, a price-to-earnings ratio of -0.04 and a beta of 0.51. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.86 and a quick ratio of 1.18. Venus Concept has a 52 week low of $0.28 and a 52 week high of $1.59.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.